Ro5-3335
Ro5-3335 is an experimental drug from the benzodiazepine family which acts as a selective inhibitor of the protein Runt-related transcription factor 1. Inhibition of this protein is useful in numerous medical applications, and Ro5-3335 has beneficial effects against diverse conditions including HIV infection, leukemia and some other forms of cancer, recovery following heart attack, acute kidney injury, and some types of retinopathy.